PURPOSE: This retrospective analysis aimed to identify whether breast cancer patients receiving radiotherapy alone following a complete clinical remission (cCR) to neoadjuvant chemotherapy had a worse outcome than those treated with surgery. PATIENTS AND METHODS: One hundred thirty-six patients who had achieved a cCR to neoadjuvant chemotherapy for early breast cancer were identified from a prospectively maintained database of 453 patients. Of these, 67 patients had undergone surgery as their primary locoregional therapy, and 69 patients had radiotherapy alone. Outcome was assessed in relation to local recurrence-free survival, disease-free survival, and overall survival. RESULTS: Median follow-up was 63 months in the surgery group and 87 months in the no surgery group. Prognostic characteristics were well balanced between the two groups. For surgery and no surgery, respectively, there were no significant differences in disease-free survival or overall survival (5-year, 74% v 76%; 10-year, 60% v 70%, P =.9) between the two groups. There was a nonsignificant trend toward increased locoregional-only recurrence for the no surgery group (21% v 10% at 5 years; P =.09), but no long-term failures of local control. Patients in the no surgery group who also achieved an ultrasound complete remission had a 5-year local recurrence rate of only 8%. CONCLUSION: In patients achieving a cCR to neoadjuvant chemotherapy, radiotherapy alone achieve survival rates as good as with surgery, but with higher local recurrence rates. Ultrasound may identify a low recurrence rate subgroup for assessing no surgery in a prospective trial.
PURPOSE: This retrospective analysis aimed to identify whether breast cancerpatients receiving radiotherapy alone following a complete clinical remission (cCR) to neoadjuvant chemotherapy had a worse outcome than those treated with surgery. PATIENTS AND METHODS: One hundred thirty-six patients who had achieved a cCR to neoadjuvant chemotherapy for early breast cancer were identified from a prospectively maintained database of 453 patients. Of these, 67 patients had undergone surgery as their primary locoregional therapy, and 69 patients had radiotherapy alone. Outcome was assessed in relation to local recurrence-free survival, disease-free survival, and overall survival. RESULTS: Median follow-up was 63 months in the surgery group and 87 months in the no surgery group. Prognostic characteristics were well balanced between the two groups. For surgery and no surgery, respectively, there were no significant differences in disease-free survival or overall survival (5-year, 74% v 76%; 10-year, 60% v 70%, P =.9) between the two groups. There was a nonsignificant trend toward increased locoregional-only recurrence for the no surgery group (21% v 10% at 5 years; P =.09), but no long-term failures of local control. Patients in the no surgery group who also achieved an ultrasound complete remission had a 5-year local recurrence rate of only 8%. CONCLUSION: In patients achieving a cCR to neoadjuvant chemotherapy, radiotherapy alone achieve survival rates as good as with surgery, but with higher local recurrence rates. Ultrasound may identify a low recurrence rate subgroup for assessing no surgery in a prospective trial.
Authors: Jennifer F De Los Santos; Alan Cantor; Keith D Amos; Andres Forero; Mehra Golshan; Janet K Horton; Clifford A Hudis; Nola M Hylton; Kandace McGuire; Funda Meric-Bernstam; Ingrid M Meszoely; Rita Nanda; E Shelley Hwang Journal: Cancer Date: 2013-02-21 Impact factor: 6.860
Authors: Audree B Tadros; Wei T Yang; Savitri Krishnamurthy; Gaiane M Rauch; Benjamin D Smith; Vicente Valero; Dalliah M Black; Anthony Lucci; Abigail S Caudle; Sarah M DeSnyder; Mediget Teshome; Carlos H Barcenas; Makesha Miggins; Beatriz E Adrada; Tanya Moseley; Rosa F Hwang; Kelly K Hunt; Henry M Kuerer Journal: JAMA Surg Date: 2017-07-01 Impact factor: 14.766
Authors: Helena M Verkooijen; Gérald M Fioretta; Elisabetta Rapiti; Hervé Bonnefoi; Georges Vlastos; John Kurtz; Peter Schaefer; André-Pascal Sappino; Hyma Schubert; Christine Bouchardy Journal: Ann Surg Date: 2005-08 Impact factor: 12.969
Authors: Shelley A Henderson; Nazleen Muhammad Gowdh; Colin A Purdie; Lee B Jordan; Andrew Evans; Tracy Brunton; Alastair M Thompson; Sarah Vinnicombe Journal: Br J Radiol Date: 2018-05-02 Impact factor: 3.039
Authors: M A Bollet; A Savignoni; J-Y Pierga; M Lae; V Fourchotte; Y M Kirova; R Dendale; F Campana; B Sigal-Zafrani; R Salmon; A Fourquet; A Vincent-Salomon Journal: Br J Cancer Date: 2008-02-05 Impact factor: 7.640